Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)
- PMID: 10339467
Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)
Abstract
Intravenous immunoglobulin (IVIg) therapy is associated with a broad range of immunomodulatory activities. Several of the postulated mechanisms of IVIg action relate to the presence of antibodies to molecules relevant for regulation of the immune response. This article reports that IVIg contains antibodies to the Arg-Gly-Asp (RGD) sequence, and the attachment site of a number of adhesive extracellular matrix proteins, including ligands for beta1, beta3, and beta5 integrins. Anti-RGD antibodies were identified in IVIg by enzyme-linked immunosorbent assay and by using the BIAcore (BIAcore, Uppsala, Sweden) technology. The affinity of anti-RGD antibodies to a synthetic RGD-containing peptide and to fibronectin (Fn) was found to be in the micromolar range. F(ab')2 fragments specific for RGD were purified from IVIg by affinity chromatography. Anti-RGD F(ab')2 antibodies inhibited adenosine diphosphate induced alphaIIb/beta3 integrin-mediated platelet aggregation and the adhesion of activated alpha4beta1 integrin-expressing B cells to Fn. Adhesion of unstimulated platelets to fibrinogen (Fg) involving both the gamma-chain dodecapeptide sequence and the RGD sequence was inhibited by anti-RGD antibodies. In addition, adhesion of thrombin-stimulated platelets to von Willebrand factor or Fg was completely inhibited by affinity-purified anti-RGD antibodies. Our results suggest that the presence of natural IgG antibodies to the RGD motif may contribute to the immunomodulatory and anti-inflammatory effects of therapeutic preparations of normal IgG.
Similar articles
-
Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.Biochem J. 1994 Dec 15;304 ( Pt 3)(Pt 3):929-36. doi: 10.1042/bj3040929. Biochem J. 1994. PMID: 7529494 Free PMC article.
-
Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.Blood. 1988 Jul;72(1):82-8. Blood. 1988. PMID: 2968824
-
Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.Thromb Haemost. 1993 Dec 20;70(6):1030-6. Thromb Haemost. 1993. PMID: 8165596
-
Toward molecular targeting with specific intravenous immunoglobulin preparation.Clin Rev Allergy Immunol. 2005 Dec;29(3):213-7. doi: 10.1385/CRIAI:29:3:213. Clin Rev Allergy Immunol. 2005. PMID: 16391396 Review.
-
[Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].Orv Hetil. 1995 Oct 1;136(40):2155-9. Orv Hetil. 1995. PMID: 7566948 Review. Hungarian.
Cited by
-
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15. Nat Rev Immunol. 2013. PMID: 23411799 Review.
-
The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.J Clin Immunol. 2013 Jan;33 Suppl 1:S27-32. doi: 10.1007/s10875-012-9842-5. Epub 2012 Dec 11. J Clin Immunol. 2013. PMID: 23229779 Review.
-
The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.J Exp Med. 2007 Mar 19;204(3):571-82. doi: 10.1084/jem.20061931. Epub 2007 Mar 5. J Exp Med. 2007. PMID: 17339406 Free PMC article.
-
Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?PLoS One. 2017 Oct 12;12(10):e0186046. doi: 10.1371/journal.pone.0186046. eCollection 2017. PLoS One. 2017. PMID: 29023507 Free PMC article.
-
Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.Clin Rev Allergy Immunol. 2005 Dec;29(3):307-10. doi: 10.1385/CRIAI:29:3:307. Clin Rev Allergy Immunol. 2005. PMID: 16391406 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous